Corcept Therapeutics | CORT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Ardelyx USD 88.6M 5.22M 2025-12
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
J&J USD 54.13B 3.26B 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12